Sanofi

Pic:getty/alekesejplantanov

Sanofi to help manufacture Janssen COVID-19 vaccine

By Rachel Arthur

Sanofi’s vaccine manufacturing plant in Marcy l’Etoile, France, will formulate and fill vials of Janssen’s COVID-19 vaccine: producing around 12 million doses a month to help address global supply demands.

Pic:getty/Yakobchuk

France ramps up COVID-19 vaccine production

By Rachel Arthur

Three COVID-19 vaccine manufacturing sites are set to start production in France in the coming weeks: while the French government is seeking to boost further production with a €300m ($363m) initiative announced on Monday.

Pic:getty/gajus

Sanofi to acquire Kymab for up to $1.45bn

By Rachel Arthur

Sanofi will acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies. The acquisition will give it global rights to KY1005, which has the potential to treat a range of immune-mediated diseases and inflammatory...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers